BioNexus Gene Lab Corp. – NASDAQ:BGLC

BioNexus Gene Lab Corp. stock price today

$5.27
+5.00
+1871.57%
Financial Health
0
1
2
3
4
5
6
7
8
9

BioNexus Gene Lab Corp. stock price monthly change

-47.21%
month

BioNexus Gene Lab Corp. stock price quarterly change

-47.21%
quarter

BioNexus Gene Lab Corp. stock price yearly change

-51.45%
year

BioNexus Gene Lab Corp. key metrics

Market Cap
4.37M
Enterprise value
91.07M
P/E
-1518.66
EV/Sales
5.53
EV/EBITDA
-253.53
Price/Sales
5.57
Price/Book
13.74
PEG ratio
3392753.60
EPS
-0.16
Revenue
9.77M
EBITDA
-2.71M
Income
-2.66M
Revenue Q/Q
0.19%
Revenue Y/Y
-4.87%
Profit margin
-0.37%
Oper. margin
-2.4%
Gross margin
11.17%
EBIT margin
-2.4%
EBITDA margin
-27.73%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

BioNexus Gene Lab Corp. stock price history

BioNexus Gene Lab Corp. stock forecast

BioNexus Gene Lab Corp. financial statements

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Profit margin
Jun 2023 2.56M -259.25K -10.1%
Sep 2023 2.55M -2.60M -102.13%
Dec 2023 2.27M 307.41K 13.52%
Mar 2024 2.38M -103.75K -4.36%
0%
Yield TTM
BioNexus Gene Lab Corp. (NASDAQ:BGLC): Payout ratio
Payout ratio 0%
BioNexus Gene Lab Corp. (NASDAQ:BGLC): Dividend Yield
2019
2020 0%
2021 0.01%
2022 0.07%
2023
BioNexus Gene Lab Corp. (NASDAQ:BGLC): Debt to assets
Jun 2023 7898940 1.93M 24.5%
Sep 2023 11465522 1.77M 15.51%
Dec 2023 11399793 1.74M 15.28%
Mar 2024 11161483 1.81M 16.28%
BioNexus Gene Lab Corp. (NASDAQ:BGLC): Cash Flow
Jun 2023 -22.04K -3.05K -4.21K
Sep 2023 -899.34K -360.71K 5.74M
Dec 2023 -261.90K -13.75K 11.11K
Mar 2024 -28.20K 15.15K 26.93K

BioNexus Gene Lab Corp. alternative data

BioNexus Gene Lab Corp. (NASDAQ:BGLC): Employee count
Aug 2023 27
Sep 2023 27
Oct 2023 27
Nov 2023 27
Dec 2023 27
Jan 2024 27
Feb 2024 27
Mar 2024 27
Apr 2024 27
May 2024 30
Jun 2024 30
Jul 2024 30

BioNexus Gene Lab Corp. other data

  • What's the price of BioNexus Gene Lab Corp. stock today?

    One share of BioNexus Gene Lab Corp. stock can currently be purchased for approximately $5.27.

  • When is BioNexus Gene Lab Corp.'s next earnings date?

    Unfortunately, BioNexus Gene Lab Corp.'s (BGLC) next earnings date is currently unknown.

  • Does BioNexus Gene Lab Corp. pay dividends?

    No, BioNexus Gene Lab Corp. does not pay dividends.

  • How much money does BioNexus Gene Lab Corp. make?

    BioNexus Gene Lab Corp. has a market capitalization of 4.37M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 10.6% to 9.77M US dollars.

  • What is BioNexus Gene Lab Corp.'s stock symbol?

    BioNexus Gene Lab Corp. is traded on the NASDAQ under the ticker symbol "BGLC".

  • What is BioNexus Gene Lab Corp.'s primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of BioNexus Gene Lab Corp.?

    Shares of BioNexus Gene Lab Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does BioNexus Gene Lab Corp. have?

    As Jul 2024, BioNexus Gene Lab Corp. employs 30 workers, which is 11% more then previous quarter.

  • When BioNexus Gene Lab Corp. went public?

    BioNexus Gene Lab Corp. is publicly traded company for more then 4 years since IPO on 8 Jan 2021.

  • What is BioNexus Gene Lab Corp.'s official website?

    The official website for BioNexus Gene Lab Corp. is bionexusgenelab.com.

  • How can i contact BioNexus Gene Lab Corp.?

    BioNexus Gene Lab Corp. can be reached via phone at +60 12 212 6512.

BioNexus Gene Lab Corp. company profile:

BioNexus Gene Lab Corp.

bionexusgenelab.com
Exchange:

NASDAQ

Full time employees:

30

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

BioNexus Gene Lab Corp., through its subsidiary, Chemrex Corporation Sdn. Bhd., engages in the wholesale of chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its chemical raw material products used to produce handrails, bench tops, automotive and aero parts, cleanroom panels, and instruments. The company, through its subsidiary, BioNexus Gene Lab Sdn. Bhd, is also involved in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Tower B, Vertical Business Suite
Kuala Lumpur, 59200

CIK: 0001737523
ISIN: US0906282076
CUSIP: 090628108